retatrutide triple agonist clinical trials Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Eli Lilly's Phase 3 clinical

Never aim the water stream directly at the powder and never inject rapidly, as both create turbulent flow that mechanically shears peptide molecules

GLP-1 receptor agonists cause diarrhea in approximately 2030% of users by accelerating gastric emptying and increasing intestinal fluid secretion

Aronnes clinical trial for orforglipron, the rate of adverse events (meaning health issues that happened during the trial, including things likely not related to the drug itself) appeared to be slightly lower than whats seen with injectables

Researchers compared cellular responses between 14 healthy older individuals aged 8091 years and 14 healthy young controls aged 1830 years, examining how aging and experimental treatments influenced chromatin condensation, mutagenic susceptibility, and chromosomal repair activity

Higher levels of the amino acid homocysteine may be associated with a higher risk of heart attack and stroke

Although many commercially available trackers such as Fitbit and Garmin encourage exercise and exertion, the Visible application is a recently designed activity monitor for those with chronic illness (553)